Eur Rev Med Pharmacol Sci 2020; 24 (17): 8628-8628
DOI: 10.26355/eurrev_202009_22771

LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647

C. Qian, C.-H. Liao, B.-F. Tan, Y.-F. Chen, B.-W. Dang, J.-L. Chen, C.-B. Liu

Department of Urological Surgery, The First People’s Hospital of Yulin, Yulin, China


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647, by C. Qian, C.-H. Liao, B.-F. Tan, Y.-F. Chen, B.-W. Dang, J.-L. Chen, C.-B. Liu, published in Eur Rev Med Pharmacol Sci 2020; 24 (6): 2938-2944–DOI: 10.26355/eurrev_202003_20658–PMID: 32271411” has been withdrawn.

 

The Publisher apologizes for any inconvenience this may cause.

LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647

Free PDF Download

To cite this article

C. Qian, C.-H. Liao, B.-F. Tan, Y.-F. Chen, B.-W. Dang, J.-L. Chen, C.-B. Liu
LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 17
Pages: 8628-8628
DOI: 10.26355/eurrev_202009_22771